Secrets of SBIR funding success

In this final installment of our three-part series, you will learn from successful North Carolina-based SBIR recipients how to successfully liaise with your SBIR funding agency. Pt. 1: Our panel of entrepreneurs talks about technical validation and R&D funding focus for a technology-oriented business. Pt. 2: Our panelists talk about SBIR-funded start-ups and growing an SBIR-funded business Read Pt. 3...

Success story: Company awarded SBIR grant to investigate growth factor development
   Affinergy, Research Triangle Park, NC

Affinergy, Inc., a Duke University spinout with a proprietary site-specific biological delivery system, was recently awarded a $256,000 Phase I SBIR grant to accelerate screening of their proprietary libraries of billions of peptides to find new molecules that mimic the positive clinical effects of growth factors currently on the market.

Read More...

SBIR proposal writing basics: Prove feasibility in the middle of Phase I

So when are you supposed to prove the feasibility of your innovation in an SBIR or STTR project? The easy answer is that the proof of technical feasibility should be achieved in the Phase I project, since that is the main purpose of Phase I.

A more useful answer to the "when-do-you-prove-feasibility" question is to consider proving it before the end of the Phase I project.

Read More...

Finding an appropriate solicitation
   by Julie Seward Nagel, PhD, Biotechnology Business Consultants, LLC

Finding an appropriate solicitation that is a match for your company's technology development goals can be a challenge. Here are four suggested rules to meet the challenge

Read More...

Success story: SBIR grant to aid patients needing total parenteral nutrition formulations

BioLink Life Sciences, Inc. of Cary, NC received Phase I SBIR funding from the National Institutes of Health (NIH) to support BioLink's initial development of a novel iron supplement for TPN (total parenteral nutrition) formulations. "Receipt of an NIH award puts us in the top 10 percent of small companies developing novel health care products," noted Dr. Deanna Nelson, BioLink's president. "This SBIR grant validates our unique approach to improving the care and quality of life of all Americans."

Read More...

7th annual NIH SBIR/STTR conference

Enjoy this free, two-day conference for small businesses conducting innovative, health-related research. Highlights include:

• opportunities to meet one-on-one with NIH staff
  
• lots of networking time
  
• opportunity to get answers to all of your SBIR/STTR questions
  
• Poster session of SBIR/STTR Phase II awardees
  

July 28-29, 2005
The Natcher Conference Center, National Institutes of Health
Bethesda, MD (http://grants.nih.gov/grants/funding/sbirconf2005/index.htm)